Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Is Small Smarter? Nanomaterial-based Detection And Elimination Of Circulating Tumor Cells: Current Knowledge And Perspectives

A. Gribko, J. Künzel, D. Wünsch, Q. Lu, Sophie Madeleine Nagel, S. Knauer, R. Stauber, Guo-Bin Ding
Published 2019 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Circulating tumor cells (CTCs) are disseminated cancer cells. The occurrence and circulation of CTCs seem key for metastasis, still the major cause of cancer-associated deaths. As such, CTCs are investigated as predictive biomarkers. However, due to their rarity and heterogeneous biology, CTCs’ practical use has not made it into the clinical routine. Clearly, methods for the effective isolation and reliable detection of CTCs are urgently needed. With the development of nanotechnology, various nanosystems for CTC isolation and enrichment and CTC-targeted cancer therapy have been designed. Here, we summarize the relationship between CTCs and tumor metastasis, and describe CTCs’ unique properties hampering their effective enrichment. We comment on nanotechnology-based systems for CTC isolation and recent achievements in microfluidics and lab-on-a-chip technologies. We discuss recent advances in CTC-targeted cancer therapy exploiting the unique properties of nanomaterials. We conclude by introducing developments in CTC-directed nanosystems and other advanced technologies currently in (pre)clinical research.
This paper references
10.1021/nl801301a
The assembly of single-layer graphene oxide and graphene using molecular templates.
Zhongqing Wei (2008)
10.1016/J.JELECHEM.2017.12.012
Copper (II) oxide nanozyme based electrochemical cytosensor for high sensitive detection of circulating tumor cells in breast cancer
L. Tian (2017)
10.1038/nm.2304
The cancer stem cell: premises, promises and challenges
H. Clevers (2011)
10.2144/99272RR02
Direct observation of nucleocytoplasmic transport by microinjection of GFP-tagged proteins in living cells.
O. Rosorius (1999)
10.1002/smll.201403658
Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells.
Weiyi Qian (2015)
10.1002/adma.201403530
Aptamer-functionalized barcode particles for the capture and detection of multiple types of circulating tumor cells.
Fuyin Zheng (2014)
10.1021/ja8015022
Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor.
André A. Adams (2008)
10.1016/J.JCONREL.2005.09.034
Block copolymer micelles: preparation, characterization and application in drug delivery.
G. Gaucher (2005)
10.2147/IJN.S45059
One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles
J. Kim (2013)
10.1002/bit.22066
Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells
L. Yang (2009)
10.1016/j.cell.2014.07.013
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
N. Aceto (2014)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1016/j.jconrel.2015.04.036
Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials.
Jingjing Xie (2015)
10.1021/ACS.CHEMMATER.7B03044
Biostable Aptamer Rings Conjugated for Targeting Two Biomarkers on Circulating Tumor Cells in Vivo with Great Precision
H. Dong (2017)
10.1039/c7nr00273d
A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.
Yu Gao (2017)
10.1021/nn5004277
Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis
H. J. Yoon (2014)
10.2147/OTT.S46200
Clinical utility of circulating tumor cell counting through CellSearch®: the dilemma of a concept suspended in Limbo
C. Raimondi (2014)
Ultrasonicationassisted one-step self-assembly preparation of biocompatible fluorescentmagnetic nanobeads for rare cancer cell detection. Nanotechnology
S Guo (2014)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.2147/NSA.S3788
Applications of gold nanoparticles in cancer nanotechnology.
W. Cai (2008)
10.1016/j.ymeth.2013.05.027
A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells.
B. P. Casavant (2013)
10.1021/ACSAMI.6B08695
"Sense-and-Treat" DNA Nanodevice for Synergetic Destruction of Circulating Tumor Cells.
Nandi Chen (2016)
10.1021/AC050413O
Development of an autofluorescent translocation biosensor system to investigate protein-protein interactions in living cells.
S. Knauer (2005)
10.1039/c2lc90148j
Probing circulating tumor cells in microfluidics.
P. Li (2013)
10.22034/APJCP.2017.18.8.2275
Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational Study
K. Ried (2017)
10.1021/acs.analchem.8b00514
Near-Infrared Fluorescent Ag2S Nanodot-Based Signal Amplification for Efficient Detection of Circulating Tumor Cells.
Caiping Ding (2018)
10.1002/anie.201105508
Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells.
J. H. Myung (2011)
10.1021/JA037088B
Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors.
A. R. Clapp (2004)
10.1016/j.bbrc.2017.10.026
Increased cellular uptake of peptide-modified PEGylated gold nanoparticles.
B. He (2017)
10.1371/journal.pone.0045557
In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles
E. Galanzha (2012)
10.1039/c5cs00217f
The nanoparticle biomolecule corona: lessons learned - challenge accepted?
D. Docter (2015)
10.1155/2014/491459
Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer
B. Jaeger (2014)
10.7150/ntno.22091
Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy
Qinqin Huang (2018)
10.1186/2045-3701-3-6
Cancer biomarkers and targeted therapies
Z. Shen (2013)
10.7314/APJCP.2014.15.2.517
PLGA-based nanoparticles as cancer drug delivery systems.
Fatemeh Sadat Tabatabaei Mirakabad (2014)
10.3390/ijms21020559
Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation
Mohsen Ghaferi (2020)
10.1002/adma.201502615
Antibody-Modified Reduced Graphene Oxide Films with Extreme Sensitivity to Circulating Tumor Cells.
Y. Li (2015)
10.1021/ac303398b
Highly specific and ultrasensitive graphene-enhanced electrochemical detection of low-abundance tumor cells using silica nanoparticles coated with antibody-conjugated quantum dots.
Y. Wu (2013)
10.1158/1078-0432.CCR-14-0894
Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli (2014)
10.1007/S12274-008-8021-8
Nano-graphene oxide for cellular imaging and drug delivery
X. Sun (2008)
10.1002/wnan.43
Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
S. Bisht (2009)
Biodegradable polymeric micelleencapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells
S Deng (2015)
10.1016/j.bios.2012.06.020
X-ray enabled detection and eradication of circulating tumor cells with nanoparticles.
M. Hossain (2012)
10.1016/j.cell.2016.11.037
Emerging Biological Principles of Metastasis
Arthur W. Lambert (2017)
10.1039/b917103g
The chemistry of graphene oxide.
D. R. Dreyer (2010)
10.1016/j.addr.2018.01.002
Size‐based separation methods of circulating tumor cells
Sijie Hao (2018)
10.1007/978-3-642-28160-0_9
Emerging technologies for CTC detection based on depletion of normal cells.
M. Lustberg (2012)
10.1038/196476A0
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
L. Vroman (1962)
10.3892/IJO.27.1.49
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
G. Doyle (2004)
10.1007/s10544-009-9305-9
Microdevice for the isolation and enumeration of cancer cells from blood
S. J. Tan (2009)
10.1016/J.ACCREVIEW.2005.06.022
Effect of different antilipidemic agents and diets on mortality: a systematic review.
M. Studer (2005)
10.1073/pnas.0703875104
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
W. He (2007)
10.1007/s12195-017-0497-4
Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells
Zhenjiang Zhang (2017)
10.1364/OE.26.033044
Label-free rapid identification of tumor cells and blood cells with silver film SERS substrate.
Y. Zhang (2018)
10.1039/c4an00758a
Construction of carbon nanotube based nanoarchitectures for selective impedimetric detection of cancer cells in whole blood.
Y. Liu (2014)
10.1002/jmri.20866
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
S. Wickline (2007)
10.1016/J.CHROMA.2007.05.064
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Siyang Zheng (2007)
10.1021/jacs.6b12236
Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip.
Myoung-Hwan Park (2017)
10.1016/j.addr.2018.01.004
Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis
A. Pramanik (2018)
10.1093/jmcb/mjs013
Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
A. Brandl (2012)
10.1016/S1367-5931(02)00347-2
Dendritic polymer macromolecular carriers for drug delivery.
A. Patri (2002)
A case of cancer in which cells similar to those in the tumors were seen in the blood after death
SK Arya (1869)
10.1517/17425247.2013.729576
Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success
M. Muthu (2013)
10.1039/B513005K
Magnetism and microfluidics.
N. Pamme (2006)
10.1038/sj.bjc.6690825
Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics
H. Engel (1999)
10.1021/acs.chemrev.5b00046
New Developments in Liposomal Drug Delivery.
Bhushan S. Pattni (2015)
10.1073/pnas.0608582104
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
10.1158/1078-0432.CCR-08-0872
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
J. D. de Bono (2008)
10.1016/j.biomaterials.2015.10.046
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.
Jiahe Li (2016)
10.1007/s10544-012-9718-8
Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system
Y. Huang (2013)
10.1002/smll.201600550
The Architecture and Function of Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention.
Yu Gao (2016)
10.1038/leu.2012.284
SIAH proteins: critical roles in leukemogenesis
O. Krämer (2013)
10.1088/1478-3967/9/1/016005
Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
Marco Wendel (2012)
10.1002/ijc.26111
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
E. Andreopoulou (2012)
10.1016/j.biomaterials.2016.10.033
Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
J. Yao (2017)
10.1038/nrc2622
Metastasis: from dissemination to organ-specific colonization
D. Nguyen (2009)
10.1186/s11671-016-1512-8
Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells
Juntao Tan (2016)
10.1088/0957-4484/19/46/465101
Nanotube-antibody biosensor arrays for the detection of circulating breast cancer cells.
N. Shao (2008)
10.1002/ijc.22941
Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potential
B. M. Lippert (2007)
10.1259/0007-1285-62-739-599
Central venous catheter placement for intravenous digital subtraction angiography: an assessment of technical problems and success rate.
C. J. Barber (1989)
10.1038/nature17038
Metastatic colonization by circulating tumour cells
J. Massagué (2016)
10.1016/j.taap.2015.11.008
The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
D. Westmeier (2016)
10.1038/nbt.4071
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
S. Li (2018)
10.3390/nano10020383
Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy
S. Siemer (2020)
10.3762/bjnano.6.88
Protein corona – from molecular adsorption to physiological complexity
L. Treuel (2015)
10.1002/adma.201503323
Anticancer Platelet-Mimicking Nanovehicles.
Q. Hu (2015)
10.1038/nnano.2012.207
Biomolecular coronas provide the biological identity of nanosized materials.
M. Monopoli (2012)
10.3109/17435390.2012.724724
The European Commission's recommendation on the definition of nanomaterial makes an impact
H. Rauscher (2013)
10.1371/journal.pone.0042048
Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck
P. Balasubramanian (2012)
10.1016/j.tibtech.2015.07.001
Biomimetic particles as therapeutics.
R. A. Meyer (2015)
DNA nanodevice for synergetic destruction of circulating tumor cells
N Chen (2016)
10.1586/erm.09.15
Current advances in research and clinical applications of PLGA-based nanotechnology
J. Lü (2009)
10.1021/acsami.6b07205
Improved SERS-Active Nanoparticles with Various Shapes for CTC Detection without Enrichment Process with Supersensitivity and High Specificity.
Xiaoxia Wu (2016)
10.1039/c1lc20270g
Microchip-based immunomagnetic detection of circulating tumor cells.
Kazunori Hoshino (2011)
10.1186/1477-3155-9-55
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines
A. Mahapatro (2011)
10.2217/17435889.2.5.681
Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy.
X. Huang (2007)
10.1039/c3lc00009e
Enrichment, detection and clinical significance of circulating tumor cells.
S. Arya (2013)
10.1016/j.molmed.2010.07.001
Circulating tumour cells in cancer patients: challenges and perspectives.
K. Pantel (2010)
10.1517/17425247.5.1.25
Liposomal nanomedicines
D. Fenske (2008)
10.3978/j.issn.2305-5839.2014.09.06
CTC enumeration and characterization: moving toward personalized medicine.
A. Toss (2014)
10.1021/acs.nanolett.7b02330
Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy.
X. He (2017)
10.1016/bs.acc.2016.03.003
Circulating Tumor Cell Isolation and Analysis.
J. Zhang (2016)
10.3892/ijo.2016.3747
Circulating tumor cell clusters: What we know and what we expect (Review)
Yupeng Hong (2016)
Physicochemical properties and cellular toxicity of (poly)aminoalkoxysilanes-functionalized ZnO quantum dots. Nanotechnology
A Aboulaich (2012)
The use of a new cell collector to isolate circulating tumor cells from the blood of patients with different stages of prostate cancer and clinical outcomes – a proof-of-concept study
G Theil (2016)
10.1126/scitranslmed.3003747
Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector
D. Issadore (2012)
10.1038/42218
Biodegradable block copolymers as injectable drug-delivery systems
B. Jeong (1997)
10.7314/APJCP.2015.16.11.4745
Secondary Circulating Tumor Cells (CTCs) but not Primary CTCs are Associated with the Clinico-Pathological Parameters in Chilean Patients With Colo-Rectal Cancer.
N. Murray (2015)
10.1021/acsnano.6b06477
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis.
Ting Kang (2017)
10.1155/2012/831263
Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.
Michael J Mitchell (2012)
10.1039/c3lc50621e
Miniaturized nuclear magnetic resonance platform for detection and profiling of circulating tumor cells.
C. Castro (2014)
10.1038/263797A0
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
10.1039/c6cc03100e
"Smart" gold nanoparticles for photoacoustic imaging: an imaging contrast agent responsive to the cancer microenvironment and signal amplification via pH-induced aggregation.
Jaejung Song (2016)
10.3390/s16010137
Graphene: The Missing Piece for Cancer Diagnosis?
S. M. A. Cruz (2016)
10.1002/btm2.10004
Biomimetic strategies for targeted nanoparticle delivery
Diana Dehaini (2016)
10.2174/0929867324666170306105350
Liposomal Nanotechnology for Cancer Theranostics.
Xiuli Yue (2018)
10.1021/ja910675v
What the cell "sees" in bionanoscience.
Dorota Walczyk (2010)
10.1002/wnan.1500
The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
H. Wang (2018)
10.1038/nrc2375
Detection, clinical relevance and specific biological properties of disseminating tumour cells
K. Pantel (2008)
10.1038/nm.1711
Chip–NMR biosensor for detection and molecular analysis of cells
Hakho Lee (2008)
10.1021/ac303789x
Supersandwich cytosensor for selective and ultrasensitive detection of cancer cells using aptamer-DNA concatamer-quantum dots probes.
Hongying Liu (2013)
10.2174/138161206779026245
Polymeric micelles for drug delivery.
S. Croy (2006)
10.1158/1078-0432.CCR-06-0823
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
S. Mocellin (2006)
10.1021/JA0454135
Resist-free patterning of surface architectures in polymer-based microanalytical devices.
R. McCarley (2005)
[The circulating tumor cells: liquid biopsy of cancer].
C. Alix-Panabières (2014)
10.1038/nnano.2013.194
Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets
H. J. Yoon (2013)
10.1073/pnas.1012539107
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
S. Stott (2010)
10.2174/1381612822666161027113654
Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
H. Yu (2017)
10.3205/cto000074
Implication of stem cells in the biology and therapy of head and neck cancer
B. Wollenberg (2011)
10.1038/NNANO.2010.267
Nanobiotechnology: Nanoparticle coronas take shape
M. Monopoli (2011)
10.1021/ac303284u
Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads.
S. Kim (2013)
10.1158/1078-0432.CCR-15-1416
Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells
T. Gorges (2015)
10.1021/BK-2012-1112.CH003
Tailoring quantum dot interfaces for improved biofunctionality and energy transfer
J. Zylstra (2012)
10.1016/j.addr.2012.09.040
Historical perspective on advanced drug delivery: how engineering design and mathematical modeling helped the field mature.
N. Peppas (2013)
10.1088/0957-4484/23/33/335101
Physicochemical properties and cellular toxicity of (poly)aminoalkoxysilanes-functionalized ZnO quantum dots.
A. Aboulaich (2012)
10.1021/cr900174j
Dendrimers as carriers for delivery of chemotherapeutic agents.
S. Medina (2009)
10.1016/J.JURO.2014.07.038
Re: TRAIL-Coated Leukocytes that Kill Cancer Cells in the Circulation
A. Atala (2014)
10.1371/journal.pone.0103918
Circulating Tumor Cells in Patients with Recurrent or Metastatic Head and Neck Carcinoma: Prognostic and Predictive Significance
S. Grisanti (2014)
10.2217/nnm.10.10
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
Ruchit Trivedi (2010)
Phosphorylation of nm23H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene
L Garzia (2008)
10.1038/nchem.907
Graphene oxide as a chemically tunable platform for optical applications.
K. P. Loh (2010)
10.1021/nn1011336
Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells.
E. Song (2011)
10.1186/1471-2407-12-178
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges (2012)
10.1002/cbin.10903
Isolation and characterization of human mesenchymal stem cells derived from synovial fluid by magnetic‐activated cell sorting (MACS)
Zhaofeng Jia (2018)
10.1016/j.toxrep.2016.01.011
Toxicity determinants of multi-walled carbon nanotubes: The relationship between functionalization and agglomeration
Manfredi Allegri (2016)
10.1186/s12951-015-0072-x
Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial
Jingjing Xie (2015)
10.1038/srep21531
In vivo acoustic and photoacoustic focusing of circulating cells
E. Galanzha (2016)
10.1083/jcb.201010021
Circulating tumor cells: approaches to isolation and characterization
M. Yu (2011)
10.2217/nnm.14.169
Gold nanoparticles for photoacoustic imaging.
W. Li (2015)
10.1126/science.1234850
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Nieto (2013)
10.1016/j.addr.2018.01.013
Clinical utility of non-EpCAM based circulating tumor cell assays.
R. G. Austin (2018)
10.1155/2014/415721
Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
N. Krawczyk (2014)
10.1016/J.SNB.2015.06.066
Epithelial cancer biomarker EpCAM determination in peripheral blood samples using a microfluidic immunosensor based in silver nanoparticles as platform
F. G. Ortega (2015)
10.1016/j.aca.2013.03.060
Microfluidic bead-based multienzyme-nanoparticle amplification for detection of circulating tumor cells in the blood using quantum dots labels.
H. Zhang (2013)
10.1158/1078-0432.CCR-04-0378
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
W. Allard (2004)
10.1016/j.cca.2013.01.018
A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
Hung-Chih Lin (2013)
10.1038/nnano.2013.181
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.
S. Tenzer (2013)
10.1016/j.addr.2018.01.011
Clinical applications of the CellSearch platform in cancer patients.
S. Riethdorf (2018)
10.1016/j.biomaterials.2015.11.001
Super natural killer cells that target metastases in the tumor draining lymph nodes.
S. Chandrasekaran (2016)
10.1186/1743-8977-9-10
Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos
A. Murray (2011)
10.3892/ijo.2012.1557
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
N. Saucedo-Zeni (2012)
10.1039/c3lc50644d
Technologies for detection of circulating tumor cells: facts and vision.
C. Alix-Panabières (2014)
10.1081/CR-100101954
Carbon Nanofibers: Catalytic Synthesis and Applications
K. D. de Jong (2000)
10.1016/j.molonc.2016.01.007
Circulating tumor cell technologies
Meghaan M. Ferreira (2016)
10.1016/j.colsurfb.2016.08.008
Adhesion-based tumor cell capture using nanotopography.
L. Shi (2016)
10.1021/nn406018q
Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles.
Carl D. Walkey (2014)
10.1016/j.ymeth.2012.06.009
Photoacoustic flow cytometry.
E. Galanzha (2012)
10.1038/sj.onc.1210822
Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility
L. Garzia (2008)
10.1039/B517615H
Gold nanostructures: engineering their plasmonic properties for biomedical applications.
Min Hu (2006)
10.1016/S0142-9612(00)00115-0
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
10.1039/c6cc02374f
Proof of concept for inhibiting metastasis: circulating tumor cell-triggered localized release of anticancer agent via a structure-switching aptamer.
Nandi Chen (2016)
10.3390/s150408595
Simultaneous Imaging of Two Different Cancer Biomarkers Using Aptamer-Conjugated Quantum Dots
Jonghwan Lee (2015)
10.7150/thno.8775
The Architecture and Biological Function of Dual Antibody-Coated Dendrimers: Enhanced Control of Circulating Tumor cells and Their Hetero-Adhesion to Endothelial Cells for Metastasis Prevention
Jingjing Xie (2014)
10.1038/nature06385
Isolation of rare circulating tumour cells in cancer patients by microchip technology
S. Nagrath (2007)
10.1002/wnan.1360
Recent advances in nanotechnology-based detection and separation of circulating tumor cells.
J. H. Myung (2016)
10.1016/J.IJPHARM.2007.10.035
Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Yi-qing Ye (2008)
10.1016/j.cell.2008.03.027
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A Mani (2008)
10.1039/c7cs00016b
Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.
J. Jackson (2017)
Prospects for graphene-nanoparticlebased hybrid sensors
PT Yin (1901)
10.3390/cancers5041691
Circulating Tumor Cell Detection and Capture by Photoacoustic Flow Cytometry in Vivo and ex Vivo
E. Galanzha (2013)
10.1016/j.jconrel.2015.07.019
Cell membrane-camouflaged nanoparticles for drug delivery.
Brian T. Luk (2015)
10.1038/nrc3820
Challenges in circulating tumour cell research
C. Alix-Panabières (2014)
10.3389/fphar.2017.00035
Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection
Yue Ming (2017)
10.1021/acs.analchem.6b04219
Highly Selective Capture Surfaces on Medical Wires for Fishing Tumor Cells in Whole Blood.
F. Scherag (2017)
10.1088/0957-4484/25/50/505603
Ultrasonication-assisted one-step self-assembly preparation of biocompatible fluorescent-magnetic nanobeads for rare cancer cell detection.
Shan Guo (2014)
10.1016/J.IJPHARM.2005.03.023
Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier.
S. Venkatraman (2005)
10.1021/acsami.7b17896
Functional Diagnostic and Therapeutic Nanoconstructs for Efficient Probing of Circulating Tumor Cells.
Yaw Opoku-Damoah (2018)
10.1016/j.jconrel.2012.02.018
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.
Michael J Mitchell (2012)
10.1016/j.bios.2013.03.040
Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles.
H. Lee (2013)
10.1016/j.nano.2014.09.014
Mesoporous silica nanoparticles in drug delivery and biomedical applications.
Y. Wang (2015)
Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine
Y Wang (2014)
10.2217/nnm.15.32
Nanotechnology for enrichment and detection of circulating tumor cells.
S. Bhana (2015)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar